ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Quiltman
|
221 |
46K |
9 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
221
|
46K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Quiltman
|
221 |
46K |
12 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
221
|
46K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Quiltman
|
221 |
46K |
25 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
221
|
46K
|
25
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Quiltman
|
221 |
46K |
17 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
221
|
46K
|
17
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Resignation of Dr Michael Thurn & appointment of John Clark
|
|
Quiltman
|
221 |
46K |
19 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
221
|
46K
|
19
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Quiltman
|
1.1K |
295K |
23 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
23
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Quiltman
|
1.1K |
295K |
20 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
20
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Quiltman
|
1.1K |
295K |
28 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
28
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PharmAust makes Head of Manufacturing appointment
|
|
Quiltman
|
37 |
8.6K |
29 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
37
|
8.6K
|
29
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Quiltman
|
1.1K |
295K |
19 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
19
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Quiltman
|
1.1K |
295K |
20 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
20
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Quiltman
|
1.1K |
295K |
36 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
36
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Quiltman
|
1.1K |
295K |
36 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
36
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Quiltman
|
1.1K |
295K |
24 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
24
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive clinical data filed with FDA to support ODD request
|
|
Quiltman
|
100 |
25K |
9 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
100
|
25K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Quiltman
|
1.1K |
295K |
20 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
20
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Quiltman
|
1.1K |
295K |
24 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
24
|
|
ASX - By Stock
|
CDX |
Re:
CDX General discussion 2024
|
|
Quiltman
|
66 |
16K |
15 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
66
|
16K
|
15
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Quiltman
|
1.1K |
295K |
23 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
23
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Quiltman
|
1.1K |
295K |
18 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
18
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Quiltman
|
1.1K |
295K |
20 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
20
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Quiltman
|
1.1K |
295K |
17 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
17
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Quiltman
|
1.1K |
295K |
24 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
24
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Quiltman
|
1.1K |
295K |
47 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
47
|
|
ASX - By Stock
|
CDX |
Re:
CDX General discussion 2024
|
|
Quiltman
|
66 |
16K |
12 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
66
|
16K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
Quiltman
|
77 |
18K |
23 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
77
|
18K
|
23
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
Quiltman
|
77 |
18K |
31 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
77
|
18K
|
31
|
|
ASX - By Stock
|
CDX |
Re:
CDX General discussion 2024
|
|
Quiltman
|
66 |
16K |
13 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
66
|
16K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final Ethics Approval for Open-Label MND Extension Study
|
|
Quiltman
|
77 |
18K |
26 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
77
|
18K
|
26
|
|
ASX - By Stock
|
CDX |
Re:
CDX General discussion 2024
|
|
Quiltman
|
66 |
16K |
13 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
66
|
16K
|
13
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Quiltman
|
1.1K |
295K |
25 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
25
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Quiltman
|
1.1K |
295K |
11 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
11
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Quiltman
|
1.1K |
295K |
24 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
24
|
|
ASX - By Stock
|
PAA |
Re:
NZT gone but hasn't forgotten
|
|
Quiltman
|
66 |
17K |
28 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
66
|
17K
|
28
|
|
ASX - By Stock
|
PAA |
Re:
NZT gone but hasn't forgotten
|
|
Quiltman
|
66 |
17K |
4 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
66
|
17K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
NZT gone but hasn't forgotten
|
|
Quiltman
|
66 |
17K |
18 |
07/04/24 |
07/04/24 |
ASX - By Stock
|
66
|
17K
|
18
|
|
ASX - By Stock
|
PAA |
Re:
NZT gone but hasn't forgotten
|
|
Quiltman
|
66 |
17K |
9 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
66
|
17K
|
9
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Quiltman
|
1.1K |
295K |
23 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
23
|
|
ASX - By Stock
|
NC6 |
Re:
General Discussion
|
|
Quiltman
|
1.3K |
336K |
6 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
1.3K
|
336K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Quiltman
|
1.1K |
295K |
23 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
23
|
|
ASX - By Stock
|
PAA |
Re:
Top 200 PAA Shareholders as at 28 March 2024
|
|
Quiltman
|
55 |
14K |
30 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
55
|
14K
|
30
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Quiltman
|
1.1K |
295K |
41 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
41
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
Quiltman
|
58 |
16K |
15 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
58
|
16K
|
15
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
Quiltman
|
58 |
16K |
16 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
58
|
16K
|
16
|
|
ASX - By Stock
|
PAA |
Re:
Mainstream media is GO
|
|
Quiltman
|
31 |
10K |
25 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
31
|
10K
|
25
|
|
ASX - By Stock
|
PAA |
Re:
Mainstream media is GO
|
|
Quiltman
|
31 |
10K |
28 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
31
|
10K
|
28
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Quiltman
|
1.1K |
295K |
3 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
3
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Quiltman
|
1.1K |
295K |
15 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
15
|
|
ASX - By Stock
|
PAA Biotech |
Re:
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst
|
|
Quiltman
|
1.1K |
295K |
27 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
1.1K
|
295K
|
27
|
|
ASX - By Stock
|
CDX |
Re:
CDX General discussion 2024
|
|
Quiltman
|
66 |
16K |
17 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
66
|
16K
|
17
|
|